Summary Receptos Inc (Receptos), formerly Receptor Pharmaceuticals, Inc. a subsidiary of Celgene Corp is a therapeutic candidate development company. The company offers development and commercialization of therapies. Its ozanimod candidate is used for relapsing multiple sclerosis, ulcerative colitis, crohn’s disease, and RPC4046 is a monoclonal antibody for the treatment of eosinophilic esophagitis. Receptos also offers therapeutics for diabetes by the usage of glucagon-like peptide-1 receptor (GLP-1R) positive allosteric modulators for the treatment of type 2 diabetes mellitus. The company's research and development services include indication studies, program development, pre-clinical studies and phase development services. It partners with pharmaceutical, contract research and biotechnology companies. Receptos is headquartered in San Diego, California, the US. Receptos Inc (RCPT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed... Research Beam Model: Research Beam Product ID: 1045317 250 USD New
Receptos Inc RCPT - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Receptos Inc RCPT - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Healthcare
  • Published On : November   2016
  • Pages : 30
  • Publisher : GlobalData
 
 
 
Summary

Receptos Inc (Receptos), formerly Receptor Pharmaceuticals, Inc. a subsidiary of Celgene Corp is a therapeutic candidate development company. The company offers development and commercialization of therapies. Its ozanimod candidate is used for relapsing multiple sclerosis, ulcerative colitis, crohn’s disease, and RPC4046 is a monoclonal antibody for the treatment of eosinophilic esophagitis. Receptos also offers therapeutics for diabetes by the usage of glucagon-like peptide-1 receptor (GLP-1R) positive allosteric modulators for the treatment of type 2 diabetes mellitus. The company's research and development services include indication studies, program development, pre-clinical studies and phase development services. It partners with pharmaceutical, contract research and biotechnology companies. Receptos is headquartered in San Diego, California, the US.

Receptos Inc (RCPT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Receptos Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Receptos Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Receptos Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Receptos Raises US$10.8 Million In Series B Financing 10
Partnerships 11
Receptos Expands Collaboration With Ono Pharma For GPCR Technology Platform 11
Receptos Enters Into R&D Agreement With Ono Pharma 13
Receptos Enters Into Collaboration With Eli Lilly 14
Licensing Agreements 15
Receptos Enters Into Licensing Agreement With AbbVie For RPC4046 15
Receptos Enters Into Licensing Agreement With Ortho-McNeil-Janssen Pharma 16
Equity Offering 17
Receptos Raises USD414 Million in Public Offering of Shares 17
Receptos Raises USD178.4 Million in Public Offering of Shares 19
Receptos Completes Public Offering Of Shares For US$117.4 Million 21
Receptos Completes IPO For US$73 Million 23
Acquisition 25
Celgene Acquires Receptos for USD7.2 Billion 25
Receptos Inc - Key Competitors 27
Key Employees 28
Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List Of Tables
List of Tables
Receptos Inc, Pharmaceuticals & Healthcare, Key Facts, 2014 1
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Receptos Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Receptos Inc, Deals By Therapy Area, 2010 to YTD 2016 8
Receptos Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Receptos Raises US$10.8 Million In Series B Financing 10
Receptos Expands Collaboration With Ono Pharma For GPCR Technology Platform 11
Receptos Enters Into R&D Agreement With Ono Pharma 13
Receptos Enters Into Collaboration With Eli Lilly 14
Receptos Enters Into Licensing Agreement With AbbVie For RPC4046 15
Receptos Enters Into Licensing Agreement With Ortho-McNeil-Janssen Pharma 16
Receptos Raises USD414 Million in Public Offering of Shares 17
Receptos Raises USD178.4 Million in Public Offering of Shares 19
Receptos Completes Public Offering Of Shares For US$117.4 Million 21
Receptos Completes IPO For US$73 Million 23
Celgene Acquires Receptos for USD7.2 Billion 25
Receptos Inc, Key Competitors 27
Receptos Inc, Key Employees 28
Receptos Inc, Subsidiaries 29

List Of Figures
List of Figures
Receptos Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Receptos Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Receptos Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter